Login / Signup

Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience.

Idris YakubuBharath RavichandranTracy SparkesRolf N BarthAbdolreza HaririanBrian Masters
Published in: Journal of pharmacy practice (2019)
Alemtuzumab induction is associated with similar outcomes to basiliximab in elderly kidney transplant recipients.
Keyphrases
  • middle aged
  • community dwelling
  • type diabetes
  • stem cells
  • cell therapy
  • smoking cessation